Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,385
Total Claims
$564K
Drug Cost
777
Beneficiaries
$726
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-55%
Opioid rate vs peers
1.0% vs 2.2% avg
-49%
Cost per patient vs peers
$726 vs $1,411 avg
-32%
Brand preference vs peers
7.2% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
1.0%
Opioid Rate
94
Opioid Claims
$553
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 675 claims · $340K
Generic: 8,682 claims · $222K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 54 | $65K |
| Rivaroxaban | 36 | $49K |
| Sitagliptin Phosphate | 28 | $40K |
| Semaglutide | 13 | $25K |
| Colesevelam Hcl | 34 | $20K |
| Empagliflozin | 12 | $18K |
| Pitavastatin Calcium | 17 | $15K |
| Rosuvastatin Calcium | 328 | $12K |
| Levothyroxine Sodium | 518 | $8,379 |
| Ezetimibe | 119 | $7,325 |
| Dexlansoprazole | 14 | $6,868 |
| Levothyroxine Sodium | 104 | $6,844 |
| Atorvastatin Calcium | 479 | $6,337 |
| Losartan Potassium | 348 | $5,457 |
| Amlodipine Besylate | 604 | $5,452 |
Prescribing Profile
Patient Profile
78
Avg Age
55%
Female
1.07
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About